R&D Partner Content The 18th PFS & Injectable Drug Devices Europe Conference Kickstart 2026 in London to explore advances in drug delivery with the experts.
R&D Partner Content The Antifibrotic Drug Development Summit returns this Novemb... Harness cross-fibrotic insights and make new connections this November in Boston
Partner Content Partner Content 7th Cell Therapy Analytical Development Summit Join us in fast-tracking the next era of safe, potent, and robust cell therapies to market!
Partner Content Partner Content 7th TIL Therapies Summit Driving the Next Generation of TIL Therapies for Solid Tumors
Partner Content Partner Content 3rd Donor Selection & Cell Source Summit Transforming Off-The-Shelf Therapies From the Start
Partner Content Partner Content LEAP TA: Life Sciences Reimagine Hiring Tactics to Compete for the Best Life Sciences Talent
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
